Seven of the 18 top-paid nonexecutive board chairs were in the pharmaceutical industry last year, according to data from intelligence provider MyLogIQ, cited by the Arizona Republic newspaper.
The other top-paid board chairs worked in the financial services or industrial products industry.
The highest paid nonexecutive board members in pharma in 2018:
1. P. Roy Vagelos (Regeneron Pharma) — $6.3 million
2. Omid Farokhzad (Selecta Biosciences) — $1.4 million
3. Steven Lund (Nu Skin Enterprises) — $1.3 million
4. Kevin Starr (Sage Therapeutics) — $1.1 million
5. Iain Dukes (Iovance Biotherapeutics) — $1 million
6. Daniel Lynch (Bluebird Bio) — $1 million
7. Daniel Lynch (Surface Oncology) — $1 million
Daniel Lynch is a board chair at both Bluebird Bio and Surface Oncology.